Experiment summary for ENCSR000CYF
doi:10.17989/ENCSR000CYF
Summary
- Status
- released
- Assay
- transcription profiling by array assay (RNA microarray)
- Biosample summary
- Homo sapiens cardiovascular progenitor cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 5 days, 10 ng/mL Bone morphogenetic protein 4 for 5 days, 6 ng/mL Activin A for 5 days
- Biosample Type
- in vitro differentiated cells
- Replication type
- isogenic
- Description
- RNA Array on human H7-hESC differentiated for 5 days
- Treatments
- 5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 5 days, 10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 5 days, 6 ng/mL Activin A (CHEBI:81351) for 5 days
- Nucleic acid type
- RNA
- Fragmentation methods
- see document
- Strand specificity
- unstranded
Attribution
ENCODE2 project
- Lab
- John Stamatoyannopoulos, UW
- Award
- U54HG004592 (John Stamatoyannopoulos, UW)
- Project
- ENCODE
- External resources
- References
- Date submitted
- January 11, 2011
- Date released
- July 31, 2012
- Treatment Time Series
- ENCSR943VLP
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 1 | 1 | Homo sapiens female embryo cardiovascular progenitor in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 5 days, 10 ng/mL Bone morphogenetic protein 4 for 5 days, 6 ng/mL Activin A for 5 days | ENCBS296AAA | ENCLB968APQ |
| 2 | 1 | Homo sapiens female embryo cardiovascular progenitor in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 5 days, 10 ng/mL Bone morphogenetic protein 4 for 5 days, 6 ng/mL Activin A for 5 days | ENCBS296AAA | ENCLB477IJN |